NextMeds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 9.2/10
Best for: semaglutide at $79/month, 59% below the typical price
What NextMeds does best is price: it charges less than most sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Prices checked August 2026
Membership is a single flat monthly charge, and inside it sit free shipping, a registered dietitian holding a license, a care coach working 1:1, telehealth visits and the drug itself where one is prescribed. Insurance is not billed. A free assessment online goes to a licensed provider, who adds a phone or video consult in states that demand one, then prescribes if it fits. Compounding pharmacies within the Next Meds network, all licensed, ship. Auto-renewal does not exist, cancellation is open, and all 50 states can order compounded tirzepatide and semaglutide.
Is NextMeds legit?
Yes. NextMeds is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 9.2/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a NextMeds promo or coupon code?
We know of no promo or coupon code for NextMeds. Its listed price is $79 a month. Coupon sites advertising "NextMeds discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how NextMeds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to NextMeds
Editorial score · methodology
Editorial score · methodology
Embody
Best for: knowing which pharmacy fills the vial: it names RedRock Pharmacy
Editorial score · methodology
NextMeds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $79/mo
- Pricing model
- Flat: the price stays the same as the dose goes up
- What's included
- Medication · Consult · Shipping · Coaching
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How NextMeds scores
Six columns, each one computed from something NextMeds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
10.0/10$79/month is 57% below the $185 median for compounded semaglutide across the sellers we compare.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
8.0/10A price is shown before the questionnaire starts.
Trust & Safety15%
7.5/10No pharmacy is named for its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Accessibility10%
10.0/10Serves 50 of 50 states.
Support10%
8.5/10The price covers the medication, clinician visits, shipping and coaching.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on NextMeds
Last checked August 2026- Checked the listed price across 2 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for NextMeds
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with NextMeds involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1NextMeds shows a price on its own site before asking anything about you, so you can compare it with other sellers before you start a questionnaire.
- 2Ask NextMeds which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes the medication, clinician visits, shipping and coaching.
- Lowest ongoing monthly price: semaglutide $79, tirzepatide $109. That leaves out membership fees, first-month rates and insurance copays.
- NextMeds serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting NextMeds
- NextMeds offers email support
Cancelling NextMeds
Taken from the terms NextMeds publishes. Terms change, so check the current policy before you subscribe.
- Cancel any time
- Yes
- Minimum commitment
- None
- Refund policy
- Refund & cancellation policy linked
- Early-termination fee
- None
GLP-1 medications NextMeds offers
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Pricing
Prices re-verified
Compounded Semaglutide Membership: medication when prescribed, telehealth visits, a care coach, a dietitian and shipping. $79 is the month-to-month rate. The headline 'from $49/mo' is the 12-month prepaid price spread by month, not a monthly rate; 3 months is $76, 6 months $73, 12 months $49. A summer promotion was set to end August 20, so $79 may be a discounted rate.
Compounded Tirzepatide Membership: medication when prescribed, telehealth visits, a care coach, a dietitian and shipping. $109 is the month-to-month rate. The advertised 'GLP-1 + GIP: $95' is the 12-month prepaid price spread by month; 3 months is $105, 6 months $100, 12 months $95. A summer promotion was set to end August 20, so $109 may be a discounted rate.
Check the price yourself before you pay
Every figure here was read off NextMeds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- Semaglutide costs $79 a month, 57% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $109 a month, 56% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, clinician visits, shipping and coaching
- Serves all 50 states
- We found no FDA warning letters issued to NextMeds
Against it
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What NextMeds charges
NextMeds charges $79/month, and holds that rate across every dose. That sits at the affordable end of what we see. Flat dose pricing matters more than it sounds: on a tiered plan the bill grows with the dose, so the figure that got you to sign up is not the one you end up paying.
- Compounded semaglutide: $79/month
- Compounded tirzepatide: $109/month
For compounded semaglutide, the median across the sellers we compare is $185/month, so NextMeds' $79 is genuinely below the middle, not just advertised that way.
Embody, at about $79/month, is the closest like-for-like alternative we review.
What NextMeds dispenses
NextMeds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two molecules with the largest published weight-loss trial programs behind them. What arrives is compounded at a licensed pharmacy, not an approved pen. That is the reason it costs less, and the reason the finished preparation carries no FDA review behind it.
Safety and disclosure
NextMeds tells you its price before you start the medical questionnaire and that it treats patients in all 50 states. It also offers coaching as part of the plan. We found no FDA warning letters issued to NextMeds. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If NextMeds will not tell you, treat that as a warning sign. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You want the FDA-approved pen specifically. Everything listed here is compounded.
- You need insurance to pay for it. NextMeds is cash-pay and does not bill insurance.
It fits if
- the lowest standing monthly cost is what you are solving for
- you want the price to stop moving as your dose climbs
- you want coaching bundled in rather than billed on top
- you need access wherever you live
Our read
NextMeds competes on price without an obvious sacrifice elsewhere: $79/month, no FDA warning letters, and wide state coverage.
The Bottom Line
What NextMeds does best is price: it charges less than most sellers we compare.
Before you pay NextMeds
Starting at $79 a month. Check today's price, then start the intake.
Where NextMeds is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If you need the FDA-approved pen rather than a compounded vial, consider Sesame Care.
- If the standing monthly cost is what decides it, consider Collective (from $59/mo).
Compare NextMeds head to head
The sellers closest to NextMeds on medication and price.
Frequently Asked Questions
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this NextMeds review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of August 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See NextMeds's current pricing
Plans start at $79 a month. Whether you qualify is a clinician's decision, made after your intake.